Prediction of Work Impact in Axial Spondyloarthritis by the Work Instability Scale: A Prospective Cohort Study of 101 Patients.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
07 2021
Historique:
accepted: 27 08 2020
pubmed: 17 9 2020
medline: 28 6 2022
entrez: 16 9 2020
Statut: ppublish

Résumé

Axial spondyloarthritis (axSpA) may have an effect on work. The Ankylosing Spondylitis Work Instability Scale (AS-WIS) assesses difficulties at work. The objective of this study was to evaluate the predictive value of the AS-WIS on work impact. This is a prospective cohort study with 2 timepoints (at baseline and after 1.5 yrs) that included patients with axSpA who had paid employment. Patients completed the AS-WIS at baseline and work instability was scored as moderate/high if ≥ 11 (0-20 scale). At follow-up, adverse work outcomes (AWO) were grouped as moderate (short-term sick leave) or severe AWO (long-term sick leave, disability, unemployment). Univariable and multivariable logistic regression analyses were performed to explain AWO. Of 101 patients, mean age 45 (SD 9) years, 52% male, disease duration was 14 (SD 8) years. The Bath AS Disease Activity Index and the Bath AS Functional Index were 34 (SD 21) and 23 (SD 23), respectively, and 69 (68%) received a tumor necrosis factor inhibitor. At baseline, 46 (46%) patients had moderate/high AS-WIS. At 1.5 years of follow-up, 37 patients (36%) had AWO: 25 patients (25%) a short-term sick leave, and 12 patients (12%, 7/100 patient-years) a severe AWO. Independent baseline factors associated with AWO were a moderate/high AS-WIS score (OR 2.71, 95% CI 1.04-7.22) and shorter disease duration (OR 0.94, 95% CI 0.89-0.99). In patients with axSpA, a moderate/high AS-WIS score was predictive of AWO in this population with well-controlled axSpA. This short questionnaire can be helpful to screen for future difficulties at work.

Identifiants

pubmed: 32934129
pii: jrheum.191397
doi: 10.3899/jrheum.191397
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1002-1006

Informations de copyright

Copyright © 2021 by the Journal of Rheumatology.

Auteurs

Irina Cucos (I)

I. Cucos, MD, Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris; Irina.cucos@yahoo.com.

Sabrina Dadoun (S)

S. Dadoun, MD, C. Hudry, MD, Private Practice, Paris.

Charlotte Jacquemin (C)

C. Jacquemin, MD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, and Rheumatology Department, Rene Dubos Hospital, Pontoise.

Sarah Kreis (S)

S. Kreis MD, S. Fabre, MD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris.

Stephanie Fabre (S)

S. Kreis MD, S. Fabre, MD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris.

Christophe Hudry (C)

S. Dadoun, MD, C. Hudry, MD, Private Practice, Paris.

Eduard Pertuiset (E)

E. Pertuiset, PhD, Rheumatology Department, Rene Dubos Hospital, Pontoise.

Bruno Fautrel (B)

B. Fautrel, PhD, L. Gossec, PhD, Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP, and Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Laure Gossec (L)

B. Fautrel, PhD, L. Gossec, PhD, Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP, and Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH